A venture capitalist has to decide whether to invest in a medical technology company that licenses intellectual property from a private IP holding company is based on a platform technology. Entrepreneur Amar Sawhney and Fred Khosravi founded Incept LLC to commercialize their multi-use hydrogel technology. The couple then spun Confluent Surgical, develop some, but not all, Incept IP. Would develop the specifics of the IP Confluent were described by a license agreement between Ince … Read more »

A venture capitalist has to decide whether to invest in a medical technology company that licenses intellectual property from a private IP holding company is based on a platform technology. Entrepreneur Amar Sawhney and Fred Khosravi founded Incept LLC to commercialize their multi-use hydrogel technology. The couple then spun Confluent Surgical, develop some, but not all, Incept IP. Would develop the specifics of the IP Confluent were described by a license agreement between Incept and Confluent. Venture capitalists Charles Warden of Schroder Ventures Life Sciences was to decide whether to invest in a Series A financing round confluence. Initially very enthusiastic about the deal, Warden is concerned about Confluent the evaluation and ability as a company to be successful if he learns at Confluent restrictions placed on the license agreement. The case describes Incept business model and its approach to managing risks at an early stage ventures. The case also deals with issues such as diversification and conservation options and the importance of trust and long-term relationships in the decision-making in corporate arenas.
To maximize their effectiveness, color cases should be printed in color.
«Hide

from
Bhaskar Chakravorti,
Toby Stuart,
James Weber
Source: Harvard Business School
16 pages.
Release date: 25 March 2009. Prod #: 809062-PDF-ENG
Incept LLC and Confluent Surgical (A) HBR case solution